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Abstract 
Toll-like receptors (TLR) are members of a highly conserved group of receptors wh1ch recognize 
conserved molecular aspects of m1crobes. The purpose of these experiments were to ascertain 
the effects of the administration of the TLR 9 agonist, CpG, on the colonization of neonatal swine 
with Salmonella. Piglets were treated within 24 hr after birth (Day 0) with CpG via oral gavage. On 
day 5 post-treatment, piglets were challenged with Salmonella orally. Daily rectal swabs were 
taken until day 1 0 post-treatment. On day 10, piglets were euthanized and gut contents and 
tissues were cultured for the presence of Salmonella. Piglets in the CpG group had a one log 
reduction of Salmonella in cecal and colon contents, and no Salmonella was detected in rectal 
contents in this group compared with Salmonella infected control pigs. Rectal swabs showed a 
reduction in fecal shedding of Salmonella on days 7-10 in CpG treated pigs. No Salmonella was 
detected in any pigs treated with CpG in the spleen or rectum. Reductions in the number of pigs 
positive for Salmonella were found in the lymph nodes, colon and cecum. The data show that CpG 
may be an effective tool in reducing Salmonella colonization and shedding in neonatal pigs and 
supports previous data in weaned pigs where CpG had similar effects on Salmonella colonization. 
Introduction 
Salmonella is an important food-borne pathogen in humans (Voetsch et at., 2004). Poultry, swine, 
and cattle are known carriers of Salmonella and are important vectors of transmission of 
Salmonella to humans (Patrick et a/., 2004). Initial interactions between cells of the host innate 
immune system and pathogens, such as Salmonella, depends on the host's recognition of 
evolutionarily conserved molecules unique to a certain class of microbes called pathogen-
associated molecular patterns (PAMPs) (Fearon & Locksley, 1996; Akira, 2001 ; Janeway & 
Medzhitov, 2002). These PAMPs are recognized by the cells of the innate system via pattern 
recognition receptors (PRRs), such as the Toll-like receptors (TLR). and this recognition initiates 
signaling pathways within the cell that result in the production and release of cytokines. 
chemokines, and activation of the cell itself (Imler & Hoffman 2001 ; Janeway & Medzhitov 2002, 
Kopp & Medzhitov 2003). The recognition and subsequent release of cytokines aids m the 
direction of the acquired arm of the immune system, leading the response towards either a T H1. 
cell-mediated response or a T H2. antibody-mediated response (Medzhitov & Janeway 1997a,b; 
Romagnani 1992). 
Bacterial DNA contains unmethylated portions of its sequence that are conserved regions called 
CpG DNA. CpG DNA is recognized by the mammalian innate immune system through TLR 9 
(Hemmi et al, 2000: Bauer et al, 2001 ). Previous studies have Indicated that CpG DNA can 
stimulate neutrophils of weaned p1gs and protect weaned pigs against a laboratory challenge with 
Salmonella choleraesuis (Genovese et al., Safe Pork 2005). In addition, CpG DNA have been 
found to stimulate the avian immune system and show protective effects against Salmonella 
challenge (He et al., 2005 ). 
The purpose of the present studies was to observe the effects of the TLR9 agonist, CpG DNA, in a 
laboratory challenge model of Salmonella choleraesuis (SC) mfect1on. 
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Materials and metods 
The sequence of the CpG DNA was as follows: 
pD19- G•G•rG•c•A·rc·G·A·rG·c·A•G•G•G•G•G•G. 
Piglets in the CpG group received 1.0 mg CpG DNA in 2ml of phosphate-buffered saline (PBS) by 
oral gavage. Pigs in the SC infected control group received an oral dose of 2ml PBS. Piglets were 
we1ghed , ear-tagged, and g1ven their respective treatment withm 24 hours after birth . The day the 
treatment was administered was designated day 0. On day 5 post-treatment, all piglets were 
weighed; piglets in infected ~roups were orally administered 2 ml of phosphate-buffered saline 
solut1on (PBS) contaimng 10 colony-form1ng units (cfu) of Salmonella choleraesws (SC). Daily 
rectal swabs were taken from all groups and cultured for the presence of SC following established 
procedures. On day 10 post-treatment, pigs were weighed , then euthanized and sections of the 
gut and lymph nodes were cultured for the presence of SC. The cecum, colon , and rectum tissues 
and the luminal contents were cultured for the presence and enumerat1on of SC, respectively. In 
addition , the liver, spleen, and ileocecal lymph nodes were cultured for the presence of SC. 
Resu lts 
Results of the SC enumerat1on studies are presented in Table 1. Treatment of neonatal swine with 
CpG within 24 hr after birth reduced the number of SC recovered from all three areas of the gut 
sampled and enumerated. In both the colon and the cecum, SC cfu were reduced by at least one 
log 10. No SC was recovered from the rectum during enumeration studies in the p1gs treated with 
CpG (a 31og10 reduction). 
Results of ennched samples of the gut and tissues are presented 1n Figure 1. In the spleen, lymph 
nodes, colon , cecum, and rectum, the number of pigs positive for SC upon enrichment was 
reduced m the CpG treatment group compared to the SC control group. Again , p1gs in the CpG 
group showed no recovery of SC 1n the rectum samples. 
Daily rectal swab data are presented in Figure 2. On the first day of sampling (Day 6), pigs m the 
CpG group had 40% SC positive rectal swabs compared to 20% in the SC control group. However, 
on Day 7, 8, 9, and 10 the CpG group had greatly reduced recovery of SC in rectal swab samples 
compared to the SC control group. 
Table 1: Enumeration of Salmonella/gram of gut contents 
Group Colon Cecum Rectum 
CpG 1 0 x 1 04 cfu/g t 1 1 x 1 04 cfu!g 
SC control 3.85 x 1 as cfu/g 1.67 x 1 as cfu/g 
t cfu = colony forming units 
0.00 cfu/g 
3.0 x 103 cfu/g 
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Figure 1: Salmonella isolated from tissues treated with CpG DNA at birth and challenged w1th SC 
24 hr after treatment 
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Figure 2: Da1ly Rectal swab data from pigs treated with CpG DNA and challenged 24hr later with 
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Discussion 
In this study, CpG DNA reduced fecal shedding and gut and tissue colonization by Salmonella 
choleraesuis in neonatal pigs. These results are similar to previous studies of CpG DNA treatment 
and reductions in Salmonella colonization in weaned pigs (Genovese et al. , Safe Pork 2005). 
Although preliminary, these results indicate that CpG DNA could be effective in reducing 
Salmonella colonization of the swine gut and perhaps reduce the load of Salmonella moving 
through swine during later stages of production. However, more research is needed to form any 
conclusions on the effectiveness of CpG DNA treatment in neonatal pigs and subsequent effects 
on Salmonella carriage in later production stages. CpG DNA has been shown as a potent 
stimulator of the innate immune system in poultry and in mammals (He et al., 2005; Genovese et 
al., SafePork 2005). The use of TLR agonists on their own or in combination with vaccines as 
adjuvants may provide effective agents for reducing both foodborne and animal disease pathogens 
in food animals. 
Conclusions 
The results of these studies prov1de a basis for further characterization of TLR agonists effects 
against pathogens in swine. CpG DNA treatment of neonatal pigs within 24 hr after birth reduced 
the levels of Salmonella choleraesuis in the cecum, colon, and rectum by at least one log1 0 and 
reduced the number of pigs positive for Salmonella choleraesuis after enrichment in the spleen and 
lymph nodes. Treatment of neonatal pigs with CpG DNA also reduced the number of pigs shedding 
Salmonella choleraesuis in their feces. Further studies are needed to determine the overall 
effectiveness of CpG DNA administration to neonatal pigs in reducing Salmonella colonization of 
the gut and of tissues and its effects throughout later stages of swine production. 
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